Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radha Rajasingham

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Open Forum Infectious Diseases|December 31, 2015
Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal MeningitisMelissa A Rolfes, Joshua Rhein, Charlotte Schutz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Cytomegalovirus Viremia Associated With Increased Mortality in Cryptococcal Meningitis in Sub-Saharan AfricaCaleb Skipper, Mark R Schleiss, Ananta S Bangdiwala, et al.
Open Forum Infectious Diseases|February 8, 2021
Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global PandemicMatthew F Pullen, Katelyn A Pastick, Darlisha A Williams, et al.
Journal of the International AIDS Society|January 22, 2026
A cluster randomized trial of Visitect CD4 Advanced Disease platform among outpatients with advanced HIV disease in UgandaElizabeth Nalintya, Elizabeth L Schwartz, Patricia Nerima, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2024
The Diagnostic Performance of the Visitect Advanced Disease Point-Of-Care CD4 Platform: A Pragmatic, Mixed-Methods, Multisite Validation, Costing, and Qualitative AnalysisElizabeth Nalintya, Preethiya Sekar, Olive L Namakula, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Tropical Medicine & International Health : TM & IH|October 5, 2016
Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, BrazilJosé E Vidal, Carolina Toniolo, Adriana Paulino, et al.
Plos One|January 6, 2018
Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detectionEdward Mpoza, Liliane Mukaremera, Didas Atwebembere Kundura, et al.
Southern African Journal of HIV Medicine|September 15, 2021
Establishing targets for advanced HIV disease: A call to actionDavid B Meya, Lillian Tugume, Vennie Nabitaka, et al.
The Journal of Infectious Diseases|March 23, 2017
Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal MeningitisSarah Lofgren, Kathy H Hullsiek, Bozena M Morawski, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Open Forum Infectious Diseases|December 31, 2015
Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal MeningitisMelissa A Rolfes, Joshua Rhein, Charlotte Schutz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Cytomegalovirus Viremia Associated With Increased Mortality in Cryptococcal Meningitis in Sub-Saharan AfricaCaleb Skipper, Mark R Schleiss, Ananta S Bangdiwala, et al.
Open Forum Infectious Diseases|February 8, 2021
Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global PandemicMatthew F Pullen, Katelyn A Pastick, Darlisha A Williams, et al.
Journal of the International AIDS Society|January 22, 2026
A cluster randomized trial of Visitect CD4 Advanced Disease platform among outpatients with advanced HIV disease in UgandaElizabeth Nalintya, Elizabeth L Schwartz, Patricia Nerima, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2024
The Diagnostic Performance of the Visitect Advanced Disease Point-Of-Care CD4 Platform: A Pragmatic, Mixed-Methods, Multisite Validation, Costing, and Qualitative AnalysisElizabeth Nalintya, Preethiya Sekar, Olive L Namakula, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Tropical Medicine & International Health : TM & IH|October 5, 2016
Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, BrazilJosé E Vidal, Carolina Toniolo, Adriana Paulino, et al.
Plos One|January 6, 2018
Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detectionEdward Mpoza, Liliane Mukaremera, Didas Atwebembere Kundura, et al.
Southern African Journal of HIV Medicine|September 15, 2021
Establishing targets for advanced HIV disease: A call to actionDavid B Meya, Lillian Tugume, Vennie Nabitaka, et al.
The Journal of Infectious Diseases|March 23, 2017
Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal MeningitisSarah Lofgren, Kathy H Hullsiek, Bozena M Morawski, et al.
Pageof 11